...
机译:FAT1肿瘤抑制剂的损失通过河马途径促进对CDK4 / 6抑制剂的抗性
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
MSKCC Breast Med Serv Dept Med New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
MSKCC Dept Pathol New York NY 10065 USA;
MSKCC Dept Pathol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
Weill Cornell Med Coll New York NY 10065 USA;
Weill Cornell Med Coll New York NY 10065 USA;
MSKCC Dept Epidemiol &
Biostat New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
MSKCC Breast Med Serv Dept Med New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
MSKCC Dept Pathol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
MSKCC Dept Pathol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Human Oncol &
Pathogenesis Program New York NY 10065 USA;
机译:FAT1肿瘤抑制剂的损失通过河马途径促进对CDK4 / 6抑制剂的抗性
机译:MiR-591通过靶向TCF4充当乳腺癌的肿瘤抑制因子,并抑制Hippo-YAP / TAZ信号通路
机译:PTPRU,作为一种肿瘤抑制因子,通过减弱河马/ YAP信号通路来抑制癌症。
机译:新型HDAC抑制剂HDAC-42通过试剂盒和组蛋白依赖性途径对恶性肥大细胞肿瘤进行生物活性
机译:定义激酶MST4在河马肿瘤抑制通路中的作用
机译:泛素E3连接酶ITCH通过抑制Hippo肿瘤抑制因子途径促进乳腺癌的进展
机译:SRC通过LATS1的酪氨酸磷酸化抑制Hippo肿瘤抑制途径
机译:sIRT3是线粒体肿瘤抑制因子和遗传损失导致小鼠模型的ER / pR阳性乳腺肿瘤连接代谢和致癌线粒体肿瘤抑制因子。调整